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It has been known for some years that certain aromatic hydrocarbons induce 
mammary tumors in some species of rodents. This paper is concerned with the 
conditions required for the rapid and invariable induction of mammary cancer 
in the rat by administering 3-methylcholanthrene v/a the gastro-intestinal tract 
and  with  some  of  the  functional  characteristics  of  the  tumors  which  were 
evoked. During  the experiments,  a  novel observation was made when it was 
found that the majority of the induced carcinomas of the breast are hormone- 
dependent,  since  they  regress  when  the  supporting  internal  secretions  are 
removed. Whilst  the  concept of hormone dependence has been established in 
human mammary cancer,  this property has not been recognized previously in 
mammary carcinomas of laboratory animals. 
Tumors develop preferentially in the mammary gland of certain strains of mice and 
rats following the remote administration of some aromatic compounds; the local ap- 
plication of such carcinogens to the region of the mammary  gland is unnecessary for the 
production of breast tumors. This effect was discovered by Lacassagne (I) who found 
that the administration of estrone induced mammary  cancer in mice of the RIII strain. 
But mammary cancer can be evoked by compounds without hormonal  activity; 
amongst  these  carcinogens  are  3-methylcholanthrene  (2),  2-acetylaminofluorene 
(2-AAF) 1 (3, 4), and 7,12-dimethylbenz-a-anthracene (DMBA)  ~ (5). This remarkable 
activity of non-estrogenic carcinogens  in inducing cancers of the mammary glands 
was first observed by Maisin and Coolen  (2)  who painted the skin of mice with 3- 
methylcholanthrene and found that,  in addition  to production of skin cancer, car- 
cinoma of the mammary gland developed in high incidence.  Mammary tumors have 
also been elicited  with great frequency after the  repeated instillation of 3-methyl- 
cholanthrene in the mouth (6), nares (7), or stomach (8) of the mouse or rat. Repeated 
intravenous injections of DMBA evoked similar tumors (5). 
* This study was aided by grants from the Jane Coffin Childs Memorial Fund for Medical 
Research, from the American Cancer Society, Inc., and from the United States Public Health 
Service. 
,2-AAF, 2-acetylaminottuorene. 
2 DMB  A, 7,12, -dimethylbenz-~-anthracene. 
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The hormonal status of the treated animals,  their lineage, and the dosage of the 
carcinogen are/actors which have been identified  as significant in the induction of 
mammary cancer by aromatic compounds. Englebreth-Holm (9)  observed that paint- 
ing the skin of mice with 3-methylcholanthrene elicited mammary cancer only in the 
females.  Mammary tumors do occur in males following the remote administration  of 
the designated carcinogens but the incidence of tumors is less than in females and the 
latent period for tumor development is prolonged. Bielschowsky (4, 10) found that the 
presence of ovaries was of high importance in accelerating the development of mam- 
mary cancer in rats fed a ration containing 2-AAF since ovariectomy decreased the 
incidence of mammary tumors; a  similar  inhibiting  effect of ovariectomy has been 
observed in rats to which 3-methylcholanthrene was administered (8). Cantarow et al. 
(11)  observed that the incidence of mammary tumors in rats fed a  diet containing 
2-AAF was greatly enhanced by simultaneous  treatment with progesterone.  There 
is a lack of agreement concerning the influence of estradio]-lT~ on the induction of 
mammary tumors in rats  treated  concomitantly with  the polycyclic hydrocarbons. 
One group of workers (5)  reported that estradiol-17~ accelerated the appearance of 
the mammary cancers and increased their incidence, whilst in other experiments (12) 
this estrogen did not modify the effect of the mammary carcinogens. Shay d  al.  (13) 
found that estradiol-17~, and testosterone as well, lessened the incidence of mammary 
cancer in methylcholanthrene-treated rats. 
Bielschowsky (14) found that the administration of 2-AAF in the food evoked mam- 
mary cancer in 70 per cent of Wistar rats but in only 4 per cent of piebald rats.  The 
daffy feeding of 4  rag. of 2-AAF was highly effective (I0)  in producing mammary 
cancer in rats but lowering the daffy dosage to l  rag. caused a considerable delay in 
carcinogenesis and reduced the number of tumors. Similarly,  Geyer d  a/.  (5)  found 
that the level of dosage of DMBA was of importance in tumor production. Following 
intragastric instillation,  3-methylcholanthrene was detected in the milk of lactating 
rats (iS). 
Most of the mammary tumors evoked by the carcinogens in rats have been classi- 
fied as adenocarcinoma (10). Sarcomas of the mammary gland (16) and benign tumors 
(fibroadenoma; adenoma)  (10,  16)  occur much less  commonly. The  carcinoma  in- 
filtrates the adjacent muscles and metastasis (8,  10) has been observed although it is 
not frequent.  Bielschowsky  (4)  succeeded  in  transplanting  the  induced  mammary 
cancers to other rats and transplantation has been done successfully by others  (12, 
16) but "takes" are rare. 
In mice the single subcutaneous implantation of 3-methylcholanthrene, 1 mg., was 
followed by the development of mammary carcinomas in 84 to 525 days (17).  In the 
experiments of Shay eta/. (8) the intragastric administration of 3-methylcholanthrene, 
2 mg. daffy, induced mammary tumors in all intact female rats; the time of appearance 
of the tumors was from 129 to 383 days. Scholler and Carnes (12)  injected DMBA 
intravenously in rats and achieved the most rapid induction of mammary cancer which 
has been reported hitherto; the median time of appearance of mammary tumors was 
59 days and 89 per cent of these rats developed cancer of the breast in 14 weeks. 
Bielschowsky (10)  found that established  mammary carcinomas, induced by car- 
cinogens in the rat, did not diminish in size after ovariectomy; but these neoplasms 
frequently regressed,  sometimes profoundly, during lactation  to reappear later--an C.  HUGGINS,  G.  BRIZIAP,  ELLI,  AND  H.  SUTTON,  JR.  27 
observation similar to that made by Haddow  (18)  and Foulds  (19)  in certain spon- 
taneous mammary tumors of mice. 
Methods 
The experiments were carried out under standardized conditions. Albino rats of the Sprague- 
Dawley strain were obtained from the dealer at age 42 days and kept thereafter in a controlled 
climate. All of the rats seemed to be free from infectious disease during the experiment. Most 
of the rats were fed a  commercial ration; hypophysectomized animals were maintained on a 
synthetic, high protein (18 per ctnO diet (20) consumed ad libitum.  All operations were carried 
out under ether anesthesia. Each of the experiments reported in this paper was repeated at 
least 3 times and in all 1860 rats were studied. 
Aromatic hydrocarbons were administered by gastric intubation, always beginning at age 
50 days; at this time the rats weighed approximately 140 to 150 gin. The compounds were dis- 
solved in sesame oil and were heated for 1 hour at 100°C.  to promote their solubility and to 
sterilize them.  Throughout this paper  dosage refers to the amount  administered each day.  The 
stomach tube was a soft rubber (No. 10 French) ~theter 6 era. long which was attached to the 
hub of a hypodermic needle; a plastic tube 1 era. in length was slipped over the upper part of 
the catheter. The rats were examined at frequent intervals for the appearance of palpable 
mammary tumors. The growth of many of the established tumors was followed by photog- 
raphy at frequent intervals and by measurement of the greatest diameters from which the 
"surface area" was calculated. 
At necropsy the tumors and the inguinal mammary glands were immersed in chilled acetone 
or neutral formalin. Histologic preparations were stained with hematoxylin and eosin, with 
Schiff's reagents  (PAS)  and  with mucicarmine.  The  site of  alkaline phosphatase was  de- 
termined in slices of the tumor and the mammary glands by the method of Gomori (21). 
The content of alkaline phosphatase was determined by the method of King and Armstrong 
(22) on homogenates. 
EXPERIMENTAL 
Mammary  tumors were  always  the first neoplasms which were detected in 
carcinogen-fed rats in the present experiments  and often they were  the only 
tumors to be observed.  The mammary  cancers manifested  themselves first as 
indurated areas in the skin or as small shot-like nodules in the deeper tissues; 
in  untreated  intact  females  both  types  of lesions  increased  in  size  in  a  few 
weeks  subsequent  to  their  appearance.  Spontaneous mammary  tumors  have 
never been observed in our colony earlier than age 500 days. 
In a  series  of 682  rats,  multiple mammary  cancers developed in all intact 
female  rats receiving  3-methylcholanthrene,  10 mg.  daily by gastric  instilla- 
tion.  The  location  of  the  tumors  was  distributed  in  percentage  as  follows: 
cervical region, 25; thoracic region, 41; abdomino-inguinal, 34. 
Influence of Dosage of 3-Methylcholanthrene.--Single feeding: In this experi- 
ment the compound dissolved in sesame  oil was given once by stomach  tube 
to 9 rats at each dose level. A  single dose of 20 rag. elicited mammary cancer 
in 2 rats at 74 and 167 days, respectively; a dose of 50 rag. evoked mammary 
cancer in 3 rats in 44 to 83 days; a dose of 75 rag. induced mammary cancer in 
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Multiple feedings:  In  this  experiment,  3-methylcholanthrene  was  adminis- 
tered by stomach tube 6 days each week. When 3-methylcholanthrene was ad- 
ministered at a dosage of 2 rag. mammary tumors developed slowly and many 
rats were free from tumors at 9 months (Table I). Doses of 5 rag., or 10 rag. 
elicited  mammary cancer  in  all  intact  rats,  the  rate  of  their  development 
being faster with a dosage level of 10 rag. 
Rats  receiving  3-methylcholanthrene,  10  rag.  daily  by  gastric  intubation 
tolerated the procedure well; in a series of 113 rats, 4 animals died before 100 
days.  Severe general  toxicity was  evident when  the  dosage  of 3-methylcho- 
TABLE I 
Effect of Dosage of 3-Methylcholantkrene on the Incidence of Palpable Mammary  Tumors 
and Time of Appearance 
The compound was administered by stomach tube 6 days each week until all rats had 
developed tumors or the animals had  been observed for 9 months. 
Daily dosage 
mg. 
2 
5 
10 
15 
20 
No. [ats 
14 
40 
109 
24* 
15 
Rats with tumors 
3 
40 
109 
24 
0 
Appearance of palpable tumors, days 
Range  Median  Mean 
69-156  -- 
47-156  64  67.9 
22-77  50  55.9 
34-69  49  49.2 
All rats died between 24 and 40 days 
* In all 72 rats were treated at this dosage level; 48 died without tumors 34 to 69 days 
after beginning the experiment. 
lanthrene was increased to 15 rag.; 66 per cent of the rats (Table I) died bdore 
mammary tumors developed. At a  dosage of 20 mg.,  all rats died  before 40 
days. 
Influence  of Various Schedules of Feeding 3-Methylcholanthrene.--3-Methyl- 
cholanthrene  was  given by stomach  tube daily  to  groups  of normal female 
rats for consecutive periods of 10 to 50 days; the incidence of palpable mam- 
mary tumors and the time of their appearance are given in Table II. In the 
group of rats fed 3-methylcholanthrene, 10 rag. for 10 days, not all of the rats 
developed mammary cancer in 5 months and the time of appearance of tumors 
was more than 4 months in some of the rats. The administration of 3-methyl- 
cholanthrene,  10 rag. for 20 to 50 days elicited mammary cancers with nearly 
the same rapidity in all of the groups (Table II). 
In  another  experiment,  groups  of  rats  were  given  3-methylcholanthrene, 
10 rag., by stomach tube for 50 days with differing frequencies varying from 1 
day to 6 days of each week; the days of administration of the compound re- 
mained  constant.  All  of  the  rats  developed mammary cancer,  regardless  of C.  HUGGINS~ G.  BRIZIARELLI,  AND  H.  SUTTON, JR.  29 
feeding 1 day or 6 days each week. The development of mammary cancer was 
somewhat retarded in some of the rats receiving the compound at weekly or 
semiweekly intervals. Giving the compound thrice weekly (Mon., Wed., Fri.) 
was  nearly as effective in the rapid  induction  of mammary cancer as more 
frequent administration (Table III). 
Influence  of Hormonal Status on the Development  of Mammary Cancer.--In 
comparison with the findings in intact rats, the incidence of mammary cancers 
was reduced and the time of their appearance was retarded in a group of rats 
which had been ovariectomized at age 42 days and which had been fed 3-methyl- 
cholanthrene, 10 rag. (Table IV). But in this group mammary cancer was ob- 
TABLE II 
Influence of Duration of Administration of 3-Methylcholanthrene on Development of Palpable 
Mammary Tumors 
3-Methylcholanthrene, 10 rag., was administered by stomach tube for varying periods 
of consecutive days. There were 10 rats in each group. 
Time of 
administration 
days 
10 
20 
30 
40 
50 
Rats without 
tumors 
Range 
48-142 
32-66 
41-66 
41-58 
48-76 
Appearance of tumors, days 
Median  I 
59 
55 
51 
48 
55 
Mean 
78.9 
51.5 
54.1 
52.1 
56.9 
served early (at 49 and 59 days, respectively) in 2 of the ovariectomized rats 
which, at necropsy were found to have the atrophy of the uterus and vagina 
which is characteristic of ovarian ablation. 
The inhibitory effect of ovariectomy on the development of mammary cancer 
in rats fed 3-methylcholanthrene, 10 rag., was overcome by the daily injection 
of estradiol-17fl,  0.1  or  1  pg.;  such  quantities  induced  estrus  in  all  of  the 
ovafiectomized rats. Mammary cancer developed in all of the animals but not 
quite so quickly as in intact controls (Table IV). It was found that large quan- 
tities of estradiol-17~ (20/zg. daily) depressed the incidence of mammary can- 
cers and retarded the time of their appearance (Table IV). 
In accord with earlier work with another carcinogen (11), the repeated intra- 
muscular injection of progesterone, 4 rag. daily, enhanced the rapidity of forma- 
tion of mammary cancer in rats fed 3-methylcholanthrene, 10 rag., concurrently. 
A novel and unexpected finding was the rapid induction of mammary cancer 
in all ovariectomized rats injected with progesterone, 4 rag. and fed 3-methyl- 
cholanthrene, 10 rag. (Table IV). 
The daily injection of dihydrotestosterone 1 rag., delayed considerably but 30  INDUCTION 0~"  M~M~rARy CARCINOMA 
did not prevent the formation of mammary cancer in rats  fed  concurrently 
with 7,12-dimethylbenz-a-anthracene,  1 rag. (Table V). 
Physiological Effects of Oral Administration of 3-Methylcholanthrene.--3-Meth- 
TABLE III 
Influence  of Frequency of Administration  of 3-Methylcholanthrene on Induction  of Palpable 
Mammary  Tumors 
3-Methyleholanthrene,  10 rag., was administered by stomach tube according to various 
schedules of administration for 50 days:  10 rats in each group. 
Frequency  of administra- 
tion, days cack week 
Appearance of tumors, days 
Range 
37-58 
44-64 
44-64 
44--56 
37-85 
49-100 
Median 
44 
51 
56 
51 
52 
69 
Mean 
47.8 
54.1 
55.9 
50.1 
58.4 
67.3 
TABLE IV 
Influence of Ovariectomy, Estradiol-17O, and Progesterone  on Incidence of Palpable Mammary 
Tumors in Rats  Treated with 3-Methylcholanthrene 
3-Methylcholanthrene,  10 rag., was given to all of these female rats by stomach  tube, 
6 days each week for 50 days. Steroids were injected  intramuscularly.  The rats were ob- 
served for 120 days. 
Category 
Intact 
Ovariectomized 
Ovariectomized 
Ovariectomized 
Ovariectomized 
Intact 
Ovariectomized 
Dosage of  No. rats  steroid 
Controls 
0  I  10 
0  10 
t~stradiol-17~ 
0,1 #g.  9 
1  9 
20  9 
Progesterone 
4  rag.  ]  10 
4  "  10 
Rat  rith 
tumors 
10 
6 
10 
10 
Appearance of palpable  tumors, days 
Range 
37-63 
49-118 
41-88 
55-83 
80-97 
30-51 
48-74 
Median 
51 
78 
55 
72 
85 
41 
56 
Mean 
50.6 
73.7 
63.1 
72.1 
40.3 
58.3 
ylcholanthrene, 10 rag. in  1  cc.  of  sesame  oil,  was  administered 6  days each 
week by gastric intubation to a  group of  10  rats; their  mates  were  fed  an 
equal amount of sesame oil. 
All of the carcinogen-fed rats had developed mammary cancer after 50 days 
of  treatment (Table VI).  There was no difference from the  control group in c.  HUGGINS,  G.  BRIZIARELLI,  AND tL  SUTTON~ JR.  31 
total  body  weight but  there  was  a  considerable  decrease  in  the weight  of the 
pituitary,  the ovaries,  and  the uterus  (Table  VI).  The weight of the inguinal 
mammary  glands,  exclusive of those containing visible carcinoma,  was similar 
TABLE V 
Influence of Dihydrotestosterone  on Incidence of Palpable Mammary  Tumors in Rats Treated 
with 7,12-Dimethylbenz-a-anthracene 
7,12-Dimethylbenz-a-anthracene,  1 mg., was given  by stomach  tube 6 days each week 
for  100  days,  to intact female rats.  Dihydrotestosterone,  1 mg., was injected intramuscu- 
larly for  84  days;  the  controls  received in 
Category  No. of rats 
Eontrols...  9 
Injected  with  dihydrotestoster- 
one.  9 
ections  of sesame  oil. 
Rats with  Appearance  of palpable tumors, days 
tumors 
Range  Median  Mean 
9  47-100  79  78.9 
5  161-204  168  177.2 
TABLE VI 
Physiolog~al Effects oJ 3-Methylcholanthrene 
3-Methylcholanthrene,  10 mg., was administered  to intact female rats,  age 50 days,  by 
stomach tube,  6 days each week, for 50 days.  Sesame oil was administered  to the control 
rats.  There were 10 rats in each group.  Mean values are given; they were obtained at ne- 
cropsy at age 101 days. 
Rats with mammary cancer ............. 
Body weight .......................... 
Mammary gland weight* ............... 
Alkaline phosphatase content of mammary 
glands ............................. 
Ovaries .............................. 
Uterus ............................... 
Adrenals ............................. 
Pituitary ............................. 
Control  3-Methylcholanthrene- 
treated 
0 
225 gm. 
352 mg. 
O. 79  4-  O. 13 units 
72 mg. 
407  " 
68  " 
11.2  4-  1.4" 
10 
226 gm. 
365 mg. 
0.53  4-  0.08 units 
52 mg. 
310  " 
62  " 
8.7  -4-  0.8" 
4-, standard deviation. 
* Inguinal mammary gland. 
:[: Alkaline phosphatase  expressed  in  King-Armstrong units  (22). 
in  the  two  groups  but  the  content  of  alkaline  phosphatase  was  considerably 
lower  in  the  mammary  glands  of  the  carcinogen-fed  rats.  A  consequence  of 
ovariectomy in  the  rat  is  a  decreased  content  of alkaline  phosphatase  in  the 
mammary  glands  accompanied  by atrophy  of epithelium  (23).  In the carcino- 
gen-treated  rats  alkaline phosphatase  content of the breast  was decreased  but 32  INDUCTION  O~F  MAMMARY  CARCINOMA 
the mammary epithelium was not atrophic; to the contrary, a moderately in- 
creased epithelial proliferation was present (Fig. 1). 
Pathology of Carcinogen-Induced Mammary Tumors. Histologic examination 
was made of 680 mammary tumors induced in intact female rats by the oral 
administration of 3-methylcholanthrene. These were classified in the following 
way: carcinoma, 678; fibrosarcoma, 2; benign tumors, 0. The fibrosarcomas in 
the mammary region developed in  ovariectomized rats  fed 3-methylcholan- 
threne, 5 rag., for 201 and 218 days, respectively. 
The carcinomas in intact rats were white and soft. Hemorrhage and necrosis 
were frequently encountered in parts of the tumors but many were free from 
these complications; complete necrosis of a  tumor was never observed. The 
growth showed a considerable similarity of cytologic pattern. The tumors con- 
tained acini lined with many layers of epithelial ceils (Fig. 2) arranged to form 
gland-like structures with papillary projections in the lumina. The lumina of 
these  glandular  structures  were  filled with  eosinophilic material  containing 
protein and, apparently, carbohydrate since it stained deeply with mucicarmine 
and the PAS reagents; this secretion also contained considerable amounts of 
alkaline phosphatase. The alkaline phosphatase reaction also served to identify 
myo-epithelial cells which were present in great numbers irregularly organized 
around and within the neoplastic glands (Figs. 2, 3). 
The earliest neoplastic changes in the mammary glands of intact rats were 
observed 20 days after beginning the feeding of 3-methylcholanthrene; at this 
time, a  considerable proliferation of epithelial cells  (Fig. 4)  was observed in 
areas of the mammary gland with penetration of the neoplasm through the 
normal acinar confines; other mammary glands of this rat did not differ cytolo- 
gically from those of untreated normal females of the same age. It was ob- 
served that the neoplastic process arose in both acini (Fig. 5) and smaller ducts 
(Fig. 6) of the breast. The nipples and terminal milk ducts never were found to 
have developed neoplasms. 
The  tumors  induced  with  3-methylcholanthrene  in  ovariectomized  rats 
differed morphologically from the neoplasms elicited in intact rats. The chief 
difference was in the epithelial cells and in secretion of the tumor acini in the 
spayed rats. Whereas in both intact and ovariectomized rats there  occurred 
neoplastic gland-like structures lined with many layers of cells and surrounded 
by myo-epithelial cells, the secretion in the lumina of the tumor acini of ovariec- 
tomized animals was devoid of alkaline phosphatase and carbohydrate. In the 
mammary tumors of spayed rats, some of the acini were lined with a single row 
of flat cells (Fig. 11), whilst other glands consisted of many layers of epithelial 
cells.  Acini  of  these  types  were  frequently observed  in  mammary  cancers 
following the removal  of the ovaries of intact rats, a matter to be considered 
later in this paper. 
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infiltration of adjacent muscles,  skin,  and  the mammary fat were observed 
frequently. Large tumors frequently developed ulcers which caused the death 
of the animal. 
Hormone Dependence of Induced Mammary Cancer.--Many of the established 
mammary cancers induced by 3-methylcholanthrene were hormone-dependent. 
These underwent a considerable diminution in size after appropriate hormonal 
modifications of  the  host  and  the  regression  was  accompanied  by  atropic 
changes, which were often profound, in the tumor cells. Less frequently, these 
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TExT-Fro. 1. Decline in surface  area of an established mammary carcinoma  induced  by 
ovariectomy  (O  -O) is contrasted with continued  growth of the neoplasm  in its untreated 
sister (O- -O). Ovariectomy  was performed  on day 8. 
same hormonal treatments failed to cause regression of the carcinoma and the 
characteristic atrophy was absent. 
In one of the experiments, tumors were induced by giving 3-methylcholan- 
threne, 10 rag. daily, by stomach tube for 50 days, at which time 54 rats had 
developed mammary cancer; the administration of the carcinogen was  then 
discontinued. After an additional 25 days, the rats were divided into groups 
which were, respectively, (a) untreated controls, (b) injected with dihydrotes- 
tosterone,  (c)  ovariectomized,  or  (d)  hypophysectomized. Another group of 
ovariectomized rats was injected intramuscularly with diethylstilbestrol, 5/zg: 
The tumors increased in size in all of the intact rats (Text-fig. 1) and also in 
ovariectomized rats injected with diethylstilbestrol (Table VII). 
All of the  tumors underwent a profound decrease in size  (Text-fig. 2) after 34  INDUCTION  OF  MAMM&RY CARCINOMA 
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TEXT-FIG. 2.  Profound decrease in surface area of an established mammary carcinoma 
foliowing hypophysectomy on day 3. 
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TEXT-FIe. 3.  Divergent growth response of mammary carcinomas of 2  rats to the daily 
injection of dihydrotestosterone. The surface area of the tumor of 1 of the rats (Q  , •) 
decreased profoundly; the neoplasm in another rat (O- -O) grew at a  rapid rate. C.  HUGGINS,  G.  BRIZIARELLI~  AND  H.  SUTTON,  JR.  35 
hypophysectomy. In 2 rats, small masses of mammary cancer (approximately 
0.5 x 0.5 cm.) were present 50 days after hypophysectomy; in 7 rats only tiny 
fibrotic masses were found. 
Ovariectomy was  performed on  8  rats  bearing  carcinogen-induced  cancer 
of the breast. There was no uniformity in the growth rate of the mammary can- 
cers after this procedure. Indeed, in 7 rats the tumor underwent a considerable 
decrease in its size (Table VII) while in one animal the tumor continued to grow 
despite deprival of the ovaries. There was a  similar divergent effect of growth 
of tumors in rats injected daily with dihydrotestosterone,  1 rag. or 2 rag. This 
TABLE  VII 
Influence of Hormonal  Modifications  on Growth of Established Mammary Tumors in Female 
Rats 
Mammary cancer was induced in 54 rats by the intragastric administration of 3-methyl- 
cholanthrene,  10 mg., for 50 days;  the compound was then  discontinued. 25  days later, 
the rats were subjected to hormonal modifications and  the  tumors were measured for an 
additional 50 days. 
Increased  size  Decreased size 
Category  No.  rats  of tumor  of turaor 
ntact: no treatment. 
ntact +  dlhydrotestosterone, 1 mg.* 
ntact +  dihydrotestosterone, 2 rag.* 
}variectomized. 
)variectomized +  diethylstilbestrol, 5 #g.* 
Iypophysectomized.. 
10 
9 
8 
8 
10 
9 
10 
2 
1 
1 
10 
0 
* Dihydrotestosterone  and  diethylstilbestrol injected  intramuscularly. 
steroid was administered to  17 intact  tumor-bearing animals.  A  considerable 
regression of mass of the mammary cancer occurred in 14 animals (Figs.  7, 8) 
whilst the tumor size increased greatly in 3 rats (Fig. 9, 10).  The two types of 
response,  respectively,  continued  growth  or  profound  depression,  are  repre- 
sented quantitatively in Text-fig. 3. 
The mammary cancers which diminished in size after the endocrine modifi- 
cations (ovariectomy, hypophysectomy, administration of dihydrotestosterone) 
exhibited thereafter a characteristic cytologic appearance of atrophy of epithe- 
lial cells, which was similar in all groups. The tumor acini were still surrounded 
by myo-epithelial cells  but  their many layers of plump epithelial  cells  were 
replaced by a single row of fiat cells (Figs. 12, 13); moreover, the acinar contents 
no longer contained cytologically detected amounts of alkaline phosphatase or 
carbohydrate.  There was  a  massive increase  in  the  interacinar  interstices  of 
cells rich in alkaline phosphatase. 
The tumors which did not decrease in size after the hormonal modifications 
contained acini lined with many layers of epithelial cells (Fig. 14).  In the acini 36  INDUCTION  OF  MAMMARY  CARCINOMA 
of such growths, the secretion characteristic of the tumors of intact rats was 
absent. 
In the tumors of 2 animals  there was  evidence that some of the cells had 
undergone  h0rmone-withdrawal  atrophy  in  response  to  ovariectomy whilst 
others were hormone-independent in  character.  In  some areas of  the  tumor 
there were atrophic acini (Fig. 15) lined with a single layer of epithelial cells, 
and there was an abundance of cells rich in alkaline phosphatase between the 
neoplastic alveoli (Fig.  16).  In adjacent areas of the tumor, acini  lined with 
many layers of cells were seen without  the  dense concentration of  alkaline 
phosphatase (Fig. 15, 16).  Clearly, the cell population of these tumors was not 
uniform in its functional or morphologic response to ovariectomy; since hor- 
mone-independent cells were abundant,  the tumor continued to grow despite 
the presence of a hormone-dependent component. 
DISCUSSION 
Under  optimal  circumstances  3-methylcholanthrene administered  by way 
of the gastrointestinal tract has a special and, indeed, an overwhelming activity 
in  producing  mammary  cancers  in  the  rat  and  with  unprecedented  speed. 
Conditions  were  found in  the  present  study  rendering  it  possible  to  evoke 
multiple cancers of the breast in every animal in less than 2 months; no excep- 
tions occurred in 18 consecutive series of experiments on a total of 180 animals. 
Mammary  cancer  was  always  the  first  neoplasm  which  was  detected  and 
usually was the only tumor found but the rats were not kept until they became 
very old. 
The earliest carcinoma was detected 20 days after beginning the feeding of 3- 
methylcholanthrene and many cancers appeared before 30 days. If there were a 
latent period of carcinogenesis, it must have been brief indeed in the case of 
these tumors. These rapid effects may be compared with those of other acceler- 
ated methods of cancer induction. Bachmann and the Kennaways (24) applied 
5,9,10-trimethylbenz-a-anthracene to the skin of mice and observed a cutane- 
ous papilloma on the 31st day.  Rous  (25)  injected a  cell-free filtrate of the 
Rous Chicken Sarcoma I  in other fowls and observed the first palpable tumors 
10 to 21 days thereafter. 
To be most serviceable as a laboratory procedure for the study of cancer of 
the breast, a method of induction must be able to induce mammary cancer in 
all of the animals in a short time. These conditions were fulfilled in the present 
experiments. According to our concept, mammary cancer can be considered to 
have been induced rapidly whenever every animal in an experimental group 
develops this tumor within  60  days.  Under  the  conditions employed in  the 
present study, the rapid induction of mammary cancer through the administra- 
tion of 3-methylcholanthrene is a function of (a) dosage of the compound, (b) 
frequency of its administration, and (c) favorable hormonal conditions in the 
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of 3-methylcholanthrene, 15 rag. (or larger amounts) given for a long time killed 
many rats before mammary cancer arose. 
Mammary carcinoma was induced in some rats by a single dose (20 to 75 rag.) 
of 3-methylcholanthrene but this result was inconstant since other rats treated 
similarly did not  develop  cancer.  For  the  rapid  development of mammary 
cancer in the present work the optimal dosage of 3-methylcholanthrene was 
10 rag. administered 6 times each week by stomach tube for 7 weeks. 
The importance of the schedule of administration of the mammary carcinogen 
was brought out in an experiment in which small amounts of 3-methylcholan- 
threne were administered to 2 groups of rats.  One group received 3-methyl- 
cholanthrene, 10 nag., at daily intervals for 10 days (total dosage 100 rag.) and 
not all of these animals had developed mammary cancer after 5 months. But 
when 3-methylcholanthrene, 10 rag., was administered at weekly intervals for 
7 weeks (total dosage 80 rag.)  every rat developed mammary cancer within 
92 days. 
The hormonal status of intact female rats, age 50 days, proved conducive 
to the induction of mammary cancer by 3-methylcholanthrene but it was not 
optimal for the development of these neoplasms. The repeated administration 
of 10 rag., of the carcinogen throughout prolonged periods caused little or no 
loss of weight but resulted in considerable changes in endocrine activity. In rats, 
so treated,  there was a  significant though partial  depression of hypophyseal 
and ovarian functions; atrophy of the mammary epithelium did not occur but 
instead there was a mild hyperplasia of the mammary tubules and despite the 
decreased  endocrine  function  mammary  cancer  developed  rapidly.  Similar 
hormonal effects and increased growth of the mammary gland had been ob- 
served earlier (26), following the repeated intramuscular injection of 3-methyl- 
cholanthrene (1 or 2 rag. daily); in those experiments mammary cancer did not 
occur, presumably because the dosage of the aromatic compound was insuffi- 
cient for carcinogenesis. 
Ovariectomy retarded the development of mammary cancer in many but not 
in all of the animals. When 3-methylcholanthrene, 10 rag., was fed daily to 
ovariectomized rats for prolonged periods,  there was a  significant slowing of 
the average time of development of the cancers although 2 members of a group 
of 10 spayed rats developed cancer of the breast before the 60th day. 
It has been shown (23)  that estradiol-17~ exerts  a  biphasic  effect on  the 
growth of transplanted mammary fibroadenoma in spayed rats: small amounts 
of phenolic estrogens profoundly accelerated  the  growth  of  the  transplants 
whilst large amounts blocked their growth. Once again, the biphasic (dosage: 
growth) effects of estradiol-17/~ on mammary tumors was seen. In the present 
experiments  moderate  amounts  of  estradiol-17fl  favored  the  incidence  and 
growth of mammary cancer in ovariectomized rats which were fed 3-methyl- 
cholanthrene whilst large amounts of the hormone hindered their development. 
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development of cancer of the breast in rats fed 3-methylcholanthrene occurred 
in animals injected concurrently with large doses of this hormone. The tumor- 
accelerating action of progesterone was manifest not only in intact rats, but, 
unexpectedly, in their ovariectomized companions. Progesterone is known to 
enhance the growth of the mammary tree but only in rats in which mammary 
development has  been incited by phenolic estrogens.  In  the present experi- 
ments  with  ovariectomized rats,  progesterone, 4  rag.,  was  very effective in 
accelerating the development of mammary cancers in animals fed 3-methyl- 
cholanthrene but in the absence of the aromatic compound, progesterone neither 
induced growth of the mammary epithelium nor evoked cancers.  It is evident 
that  3-methylcholanthrene can  substitute  for  phenolic estrogens  in  the  pri- 
mary incitement of mammary growth of the type that is promoted by proges- 
terone. 
The  cytologic appearance  of  the  carcinomas  induced by 3-methylcholan- 
threne in intact rats was remarkably similar in all cases but divergent responses 
of the established tumors to hormonal modifications were observed. A uniform 
carcinogenic cause was not followed by tumors possessing identical physiologic 
characteristics;  the  elicited  tumors  varied  in  their  functional  response  to 
hormonal changes in their hosts. 
Many of the  induced carcinomas,  indeed the majority of them,  regressed 
markedly in size when ovarian function was abolished by ovariectomy or by 
hypophysectomy; removal of the pituitary always was followed by the greatest 
decline in tumor size. Cancers behaving in this way are by definition hormone- 
dependent. This decrease in size was not due to necrosis but to atrophy of the 
epithelial cells, resulting in a characteristic histologic appearance. 
Similarly,  the  administration  of  dihydrotestosterone  caused  hormone- 
dependent cancers to decrease in size; this compound, in common with other 
androgenic substances,  is known to induce a  decline of ovarian function yet, 
notably, promotes growth intensely in the normal mammary epithelium of the 
rat (27, 28). It was of interest to observe vigorous growth of the normal mam- 
mary tree in rats injected with dihydrotestosterone whilst the mammary can- 
cers became atrophic in the same animals. 
A  minority of  the  induced mammary  cancers  continued  to  grow  despite 
ovariectomy or the administration of dihydrotestosterone; tumors of this type 
are hormone-independent. In several cases, mammary tumors continued to grow 
after ovariectomy but, amidst the proliferating tissue, areas existed consisting 
of shrunken tumor cells (Figs. 15, 16). It would appear that not all of the cells 
even in a single tumor were uniform in their response to hormone withdrawal. 
Some of the cells of the induced mammary cancers in the rat possess a  bio- 
chemical mechanism that enables them to grow in the absence of those hor- 
mones which are essential for the growth of other cancer cells  and of normal 
mammary epithelium as well. C. HUGGINS,  G. BRIZIARELLI,  AND  H. SUTTON,  JR.  39 
In various strains of mice possessing the milk agent, spontaneous mammary 
cancers which have reached palpable  size do not  regress after ovariectomy, 
hypophysectomy, or the admluistration of testosterone (29). In this regard the 
mouse tumors differ from many mammary cancers of man. But the response of 
the carcinogen-induced mammary cancers of the rat to hormonal modifications 
of these kinds are reminiscent of the effects of these procedures on cancers of 
the human breast for which they serve as close experimental models which are 
unique at the present time. 
CONCLUSION 
A study was made of the optimal conditions for the induction of mammary 
cancer in  the rat.  3-Methylcholanthrene was  administered via  the  gastroin- 
testinal tract, and a simple technique was worked out for inducing mammary 
cancer regularly and rapidly. Under conducive conditions, which were readily 
reproduced, multiple mammary carcinomas and these tumors only were induced 
in every rat in repeated experiments in 60 days or less. In the strain of animal 
employed in the present experiments, the rapid induction of mammary cancer 
proved to be a function of (a) dosage, (b)  the timing of administration of the 
aromatic hydrocarbon, and (c) a favoring hormonal status of the recipient. 
Most  of  the  established  tumors  were hormone-dependent  because  they di- 
minished markedly in size after hormone withdrawal through ovariectomy or 
hypophysectomy. Similar regression of the tumors was frequently achieved by 
the  administration  of  dihydrotestosterone.  Shrinkage  of  the  cancers  was 
accompanied by atrophic changes. Experimental mammary tumors with these 
physiologic characteristics have not been recognized hitherto. 
The minority of mammary cancers continued to  grow  after ovariectomy; 
these are hormone-independent  tumors and  tumors  of  this sort  had  a  char- 
acteristic cytologic appearance following modification of the endocrine state. 
The cell population of a single tumor was not always uniform in its response 
to appropriate hormonal modifications. In certain tumors in response to changes 
in the endocrine status of the host many of the cells underwent atrophy whilst 
other adjacent cells in the same tumor continued to grow so that the net result 
was a hormone-independent tumor. 
Hypophysectomy was the most effective method found to induce regression 
of mammary cancer in the present experiments. 
We are indebted to Lorraine Grand, Filomena Brillantes, and Eustus Lauagan for technical 
assistance. 
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EXPLANATION OF PLATES 
Unless stated otherwise, the photomicrographs axe of paraffin sections stained with 
hematoxylin and eosin. In Figs. 2, 3, 5, and 16 the site of alkaline phosphatase was 
demonstrated by the method of Gomori (21). 
PLATE  4 
FIG. 1.  Mammary gland of an intact female rat age 101 days showing slight hyper- 
plasia of  the  tubules  induced  by  the  intragastric administration  of  3-methylcho- 
lanthrene, 10 rag., for 50 days. X  150. 
FIG. 2.  The distribution of alkaline phosphatase in a mammary cancer induced by 
3-methylcholanthrene in an intact female rat. The tumor acini, surrounded by myo- 
epithelial cells, consist of many layers of epithelial cells; the secretion in the lumina 
contains alkaline phosphatase.  X  730. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 109  PLATE  4 
(Huggins et al.: Induction of mammary carcinoma) PLATE  5 
FIG. 3.  The site of alkaline phosphatase in a  mammary carcinoma arising in an 
intact female rat fed 3-methylcholanthrene. The enzyme is present predominantly in 
the capillaries, the acinar secretion, and in the myo-epithelial cells which surround the 
glands and are displaced amongst the epithelial cells.  X  225. 
Flc. 4.  Mammary carcinoma which arose after feeding 3-methylcholanthrene, 10 
rag., to an intact female rat for 20 days, at which time necropsy was performed. This 
tumor was the earliest one observed in the present experiments. ~< 250. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  109  PLATE  5 
(Huggins e! a/.: Induction of mammary carcinoma) PLATE  6 
FIo. 5.  Whole mount of the mammary gland of an intact female rat fed 3-methyl- 
cholanthrene for 50 days. The arrows point to carcinomas which have arisen in 3 of the 
acini; normal acini are shown on the right.  X  65. 
FIG. 6.  Mammary  carcinoma  arising  in  a  small duct  in  an  intact  female  rat  fed 
3-methylcholanthrene  for 30  days.  A  normal  mammary  duct  is shown on the right. 
×  250. TtlE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  109  PLATE  6 
(Huggins et al.: Induction of mammary carcinoma) PLATE  7 
FIG. 7.  Multiple mammary carcinomas, induced in an intact female rat, by feeding 
3-methylcho|anthrene; this picture was taken before the administration of dihydro- 
testosterone. 
FIG. 8.  The same rat shown in Fig. 7. The mammary cancers have regressed follow- 
ing the injection of dihydrotestosterone, 1 rag., for 33 days. 
FIG. 9.  Mammary carcinomas, induced in an intact female rat, by feeding 3-methyl- 
cholanthrene, photographed before the administration of dihydrotestosterone. 
FIG. 10.  The same rat shown in Fig. 10. The mammary cancers have grown despite 
the injection of dihydrotestosterone, 1 rag., for 33  days. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  109  PLATE  7 
(Huggins et al.: Induction of mammary carcinoma) PLATE  8 
FIG.  11.  Mammary  carcinoma which arose in an ovariectomized rat after feeding 
3-methylcholanthrene, 5 rag. for 271 days. The acini are lined with flat epithelial cells. 
×  30O. 
FIG. 12.  Hormone-withdrawal  atrophy  in  a  mammary  cancer  33  days  after  re- 
moval of  the ovaries. The  epithelium  lining  the  tumor  acini has  been  reduced  to  a 
single layer of small cells.  X  300. 
FIG.  13.  Atrophy  in  a  mammary  cancer  following the injection of dihydrotestos- 
terone,  1 rag., for 33 days.  ×  170. 
Fro.  14.  Histologic  appearance  of  a  mammary  cancer  which  progressed  despite 
the injection of dihydrotestosterone,  1 mg.  for 33  days.  The tumor  consists  of solid 
cords of cells.  X  200. TItE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  109  PLATE  8 
(Huggins el al.: Induction of mammary carcinoma) PLATE  9 
FIG. 15.  Appearance 33 days after ovariectomy of an induced mammary cancer in 
the rat showing hormone-withdrawal atrophy (]eft)  adjacent to growth of hormone- 
independent tumor cells. The atrophic area consists of acini lined with a single layer 
of epithelial cells similar to those shown in Fig.  11. The hormone-independent cells 
are similar to those shown in Fig. 14.  X  170. 
FI(3. 16.  A section adjacent to that shown in Fig. 15, in which  the site of alkaline 
phosphatase has been demonstrated. An abundance of the enzyme is present in the 
cells between the atrophic acini (left).  X  170. THE  JOURNAL  OF  EXPERIMENTAl,  MEDICINE  VOL.  109  PLATE  9 
(Huggins el al.:  Induction of mammary carcinoma) 